Parkside Financial Bank & Trust’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $22.7K | Buy |
|
|||||
|
2025
Q2 | $12.2K | Buy |
|
|||||
|
2025
Q1 | $6.53K | Buy |
|
|||||
|
2024
Q4 | $2.05K | Buy |
|
|||||
|
2024
Q3 | $231 | Hold |
|
|||||
|
2024
Q2 | $276 | Hold |
|
|||||
|
2024
Q1 | $276 | Hold |
|
|||||
|
2023
Q4 | $264 | Sell |
|
|||||
|
2023
Q3 | $563 | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $1.11K | Hold |
|
|||||
|
2022
Q4 | $1.31K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $1K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $12K | Hold |
|
|||||
|
2018
Q3 | $21K | Hold |
|
|||||
|
2018
Q2 | $17K | Hold |
|
|||||
|
2018
Q1 | $14K | Buy |
|
|||||
|
2017
Q4 | $11K | Buy |
|